• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高流量鼻导管能改善 COPD 患者加重期后的呼吸效率和通气比值。

High flow nasal cannula improves breathing efficiency and ventilatory ratio in COPD patients recovering from an exacerbation.

机构信息

Médecine Intensive - Réanimation, CHU d'Angers, Vent'Lab, Université d'Angers, 4 Rue Larrey, 49100 Angers, France; Adult Intensive Care Unit, University Hospital and University of Lausanne, 46 Route du Bugnon, 1011 Lausanne, Switzerland.

Médecine Intensive - Réanimation, CHU d'Angers, Vent'Lab, Université d'Angers, 4 Rue Larrey, 49100 Angers, France.

出版信息

J Crit Care. 2022 Jun;69:154023. doi: 10.1016/j.jcrc.2022.154023. Epub 2022 Mar 26.

DOI:10.1016/j.jcrc.2022.154023
PMID:35349909
Abstract

BACKGROUND AND STUDY PURPOSE

High flow nasal cannula (HFNC) may improve CO elimination by washing out CO from the upper airways. This study aimed at assessing the effect of HFNC on minute ventilation and ventilatory ratio (VR), a surrogate of dead space, in patients hospitalized for acute hypercapnic COPD exacerbation.

METHODS

Physiological study comparing HFNC at 40 L/min to low flow oxygen. Variations of tidal volume (VT) and minute ventilation between the two treatments were estimated from chest plethysmography. Respiratory rate (RR) and arterial blood gases were measured. Variations in VR were calculated. Data were compared using Wilcoxon tests.

RESULTS

Recordings performed in 10 patients. Minute ventilation was reduced with HFNC by -16.2 [-30.9-0.4] % (p = 0.049). VT was not different but RR was lower during HFNC. PaCO was lower with HFNC compared to standard oxygen: 48.7 [46.4-58.1] vs 50.7 [48.4-57.5] mmHg (p = 0.020). VR decreased by -18.0 [-34.7 - -4.0] % (p = 0.020) with HFNC.

CONCLUSIONS

In patients recovering from acute COPD exacerbation, the use of HFNC reduced RR, minute ventilation, PaCO and VR compared to standard oxygen. These changes are consistent with a decrease in physiologic dead space with HFNC.

摘要

背景和研究目的

高流量鼻导管(HFNC)可能通过从上气道冲洗出 CO 来改善 CO 的清除。本研究旨在评估 HFNC 对因急性高碳酸血症性 COPD 加重而住院的患者分钟通气量和通气比(VR),即死腔的替代指标的影响。

方法

比较 HFNC 40 L/min 与低流量吸氧的生理研究。通过胸壁测容法估计两种治疗方法下潮气量(VT)和分钟通气量的变化。测量呼吸频率(RR)和动脉血气。计算 VR 的变化。使用 Wilcoxon 检验比较数据。

结果

记录了 10 例患者的数据。HFNC 可使分钟通气量减少 -16.2[-30.9-0.4]%(p = 0.049)。VT 无差异,但 HFNC 时 RR 较低。与标准氧相比,HFNC 时 PaCO 较低:48.7[46.4-58.1]与 50.7[48.4-57.5]mmHg(p = 0.020)。HFNC 时 VR 下降-18.0[-34.7- -4.0]%(p = 0.020)。

结论

在急性 COPD 加重后恢复的患者中,与标准氧相比,HFNC 可降低 RR、分钟通气量、PaCO 和 VR。这些变化与 HFNC 时生理死腔减少一致。

相似文献

1
High flow nasal cannula improves breathing efficiency and ventilatory ratio in COPD patients recovering from an exacerbation.高流量鼻导管能改善 COPD 患者加重期后的呼吸效率和通气比值。
J Crit Care. 2022 Jun;69:154023. doi: 10.1016/j.jcrc.2022.154023. Epub 2022 Mar 26.
2
Comparison of High-Flow Nasal Cannula with Conventional Oxygen Therapy in Patients with Hypercapnic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.高流量鼻导管与常规氧疗在高碳酸血症性慢性阻塞性肺疾病患者中的比较:系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2023 May 16;18:895-906. doi: 10.2147/COPD.S402506. eCollection 2023.
3
The use of high-flow nasal cannula in patients with chronic obstructive pulmonary disease under exacerbation and stable phases: A systematic review and meta-analysis.高流量鼻导管在慢性阻塞性肺疾病加重期和稳定期患者中的应用:系统评价和荟萃分析。
Heart Lung. 2023 Jul-Aug;60:116-126. doi: 10.1016/j.hrtlng.2023.02.016. Epub 2023 Mar 23.
4
[Effect of high-flow nasal cannula oxygen on patients with chronic obstructive pulmonary disease and mild hypercapnia: a retrospective cohort study based on the Medical Information Mart for Intensive Care-IV database].高流量鼻导管吸氧对慢性阻塞性肺疾病合并轻度高碳酸血症患者的影响:一项基于重症监护医学信息集市-IV数据库的回顾性队列研究
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jun;33(6):686-691. doi: 10.3760/cma.j.cn121430-20210219-00258.
5
High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study.高流量鼻导管氧疗与无创通气治疗慢性阻塞性肺疾病合并急性中度高碳酸血症呼吸衰竭的比较:一项观察性队列研究。
Int J Chron Obstruct Pulmon Dis. 2019 Jun 5;14:1229-1237. doi: 10.2147/COPD.S206567. eCollection 2019.
6
High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial.高流量鼻导管与常规氧疗治疗伴有轻度高碳酸血症的急性 COPD 加重:一项多中心随机对照试验。
Crit Care. 2022 Apr 15;26(1):109. doi: 10.1186/s13054-022-03973-7.
7
Development in PaCO over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial.COPD 合并持续性高碳酸血症呼吸衰竭患者经高流量鼻导管治疗 12 个月后 PaCO2 的变化:一项随机对照试验的事后分析。
BMJ Open Respir Res. 2020 Nov;7(1). doi: 10.1136/bmjresp-2020-000712.
8
Effects of heated and humidified high flow gases during high-intensity constant-load exercise on severe COPD patients with ventilatory limitation.高强度持续负荷运动期间,温热湿化高流量气体对存在通气受限的重度慢性阻塞性肺疾病患者的影响。
Respir Med. 2016 Sep;118:128-132. doi: 10.1016/j.rmed.2016.08.004. Epub 2016 Aug 8.
9
Effects of high-flow nasal cannula in patients with persistent hypercapnia after an acute COPD exacerbation: a prospective pilot study.高流量鼻导管在急性 COPD 加重后持续性高碳酸血症患者中的作用:一项前瞻性初步研究。
BMC Pulm Med. 2020 Jan 13;20(1):12. doi: 10.1186/s12890-020-1048-7.
10
High-Flow Nasal Cannula for Chronic Obstructive Pulmonary Disease with Acute Compensated Hypercapnic Respiratory Failure: A Randomized, Controlled Trial.高流量鼻导管在慢性阻塞性肺疾病合并急性代偿性高碳酸血症呼吸衰竭中的应用:一项随机对照试验。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 24;15:3051-3061. doi: 10.2147/COPD.S283020. eCollection 2020.

引用本文的文献

1
Gas composition and pressure in the hypopharynx during high-flow oxygen therapy through a nasal cannula in healthy volunteers with different breathing patterns.不同呼吸模式的健康志愿者通过鼻导管进行高流量氧疗时下咽的气体成分和压力
BMC Anesthesiol. 2025 Aug 23;25(1):416. doi: 10.1186/s12871-025-03267-9.
2
Management of Asthma and COPD Exacerbations in Adults in the ICU.成人重症监护病房中哮喘与慢性阻塞性肺疾病急性加重的管理
CHEST Crit Care. 2025 Mar;3(1). doi: 10.1016/j.chstcc.2024.100107. Epub 2024 Nov 8.
3
High-flow oxygenation therapy for a sedated elderly frail patient with hiccups undergoing transcatheter aortic valve implantation.
高流量氧疗用于一名接受经导管主动脉瓣植入术的镇静老年体弱呃逆患者。
JA Clin Rep. 2025 Apr 21;11(1):22. doi: 10.1186/s40981-025-00784-x.
4
Home high-flow therapy during recovery from severe chronic obstructive pulmonary disease (COPD) exacerbation: a mixed-methods feasibility randomised control trial.重度慢性阻塞性肺疾病(COPD)加重期恢复期间的家庭高流量治疗:一项混合方法可行性随机对照试验
BMJ Open Respir Res. 2025 Jan 6;12(1):e002698. doi: 10.1136/bmjresp-2024-002698.
5
High-velocity nasal insufflation versus noninvasive positive pressure ventilation for moderate acute exacerbation of chronic obstructive pulmonary disease in the emergency department: A randomized clinical trial.急诊科中高速经鼻吹气与无创正压通气治疗慢性阻塞性肺疾病中度急性加重的随机临床试验
Acad Emerg Med. 2025 Apr;32(4):403-413. doi: 10.1111/acem.15038. Epub 2024 Dec 11.
6
The effect of high-flow oxygen via tracheostomy on respiratory pattern and diaphragmatic function in patients with prolonged mechanical ventilation: A randomized, physiological, crossover study.经气管切开给予高流量氧气对长期机械通气患者呼吸模式和膈肌功能的影响:一项随机、生理学、交叉研究。
J Intensive Med. 2024 Jan 4;4(2):202-208. doi: 10.1016/j.jointm.2023.11.008. eCollection 2024 Apr.
7
Cost-Effectiveness of Humidified High-Flow Therapy (HHFT) for COPD Patients on Long-Term Oxygen Therapy.长期氧疗的慢性阻塞性肺疾病患者使用高流量湿化氧疗(HHFT)的成本效益分析
Clinicoecon Outcomes Res. 2023 Apr 5;15:239-250. doi: 10.2147/CEOR.S400739. eCollection 2023.
8
Journal Club: Impaired Ventilatory Efficiency and Exercise Intolerance in Former/Current Smokers With Dyspnea Disproportionate to Their Lung Function: Pathophysiological Insights Gained Through Cardiopulmonary Exercise Testing.期刊俱乐部:肺功能不相称的呼吸困难的既往/当前吸烟者的通气效率受损和运动不耐受:通过心肺运动试验获得的病理生理学见解
Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):477-485. doi: 10.15326/jcopdf.2022.0344.